Kenya will receive genomic sequencing support through the UKs New Variant Assessment Platform Programme as part of the Kenya-UK health partnership.
A statement by the British High Commission in Nairobi read that, the platform aims to support country’s effectively identify, assess and track new coronavirus variants among their population, to fight COVID-19 and future pandemics.
The platform will allow the UKs unique sequencing and variant assessment capabilities to support Kenya’s response to COVID-19, thus strengthening global health security.
The support includes reagents and equipment to increase in-country sequencing, technically advice, bioinformatics support, and training.
The partnership will be between Kenya’s KEMRI and the UKs Public Health England.
Kenya’s Health Cabinet Secretary Mutahi Kagwe said, “the contribution and support from the UK on genomic sequencing will assist in the response to the current pandemic, and will help us fight future pandemics together.”
“Through KEMRI and Oxford University, we have a 30 year health partnership which continues to grow from strength to strength, as we continuously expand our scope of cooperation in the health sector.” He added.
The commission further stated that plans are also in development, of the UK to assist in establishment of two regional hubs, they include: the African Centre for Disease Control in Addis Ababa, Ethiopia. The other in Singapore.
(With input from the British High Commission)